After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for 10x Genomics Inc (TXG) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $1.62, or 4.27%, to $39.55. The 10x Genomics Inc has recorded 13,004 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study.
TXG belongs to the Healthcare sector of the NASDAQ while operating in the Health Information Services industry. At the end of the last regular session, the stock closed at $37.93 and fluctuated between $39.02 as its day high and $37.43 as its day low. The current market capitalization of 10x Genomics Inc is $4.45B. A total of 1.0 million shares were traded on the day, compared to an average of 958.29K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, TXG has seen 0 BUY and 9 SELL insider trades, representing the acquisition of 0 and the disposition of 25,750 shares. Over the last 12 months, there were 16 BUYs and 53 SELLs from insiders. Insiders purchased 401,666 shares during that period but sold 160,867.
In the most recent transaction, Saxonov Serge sold 1,979 shares of TXG for 39.51 per share on Oct 17. After the transaction, the Chief Executive Officer now owns 856,926 company shares. In a previous transaction on Oct 16, Saxonov Serge sold 21 shares at 39.50 per share. TXG shares that Chief Executive Officer owns now total 858,905.
Among the insiders who sold shares, Saxonov Serge disposed of 2,000 shares on Sep 14 at a per-share price of $49.37. This resulted in the Chief Executive Officer holding 862,093 shares of TXG after the transaction. In another insider transaction, Wilbur James sold 9,699 shares at $45.78 per share on Aug 22. Company shares held by the Chief Commercial Officer now total 101,253.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for TXG in the last 3 months, the mean price target is $54.83 with high estimates of $70.00 and low estimates of $30.00. In terms of 52-week highs and lows, TXG has a high of $63.57 and a low of $30.19.
As of this writing, TXG has an earnings estimate of -$0.46 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.58. The company reported an EPS of -$0.44 in the last quarter, which was -18.90% lower than expectations of -$0.37.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.30, while its Total Shareholder’s Equity was $817.57M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 4.08.